You are on page 1of 2

Sales Force Training for Rare and Ultra-Rare Diseases

The rare disease landscape is complicated, and effective sales force training in this arena can be even more so. Meredith Xcelerated Marketing (MXM) Health is the leader in unique and engaging training within the rare and ultrarare disease state space.
We encompass a total solution that includes: In-house medical expertise A thorough understanding of the concerns and the spheres of influence around medical specialists Deep experience in training seasoned representatives to deliver in this niche space MXM Health is uniquely positioned to deliver all of this combined with an unwavering commitment to these special patients. We believe sales forces in the rare disease space must be built to excel in 5 main areas:

IDENTIFICATION AND CREATION


Generate medical champions of the brand and the treatment

PATH DEVELOPMENT
Build paths for differential diagnosis and management

KNOWLEDGE
Be as informed and conversant as the customers

PATIENT AND PHYSICIAN INSIGHT


Possess a wide understanding of patient and customer journeys as well as the medical specialists' spheres of influence

REIMBURSEMENT
Be skilled in support of the reimbursement process

MXM Health has proven expertise in science and medicine, communications, adult learning, and technology. We also have a solid history of leveraging these areas of expertise as leaders of sales training for rare and ultra-rare diseases. In the last 2 years alone weve developed and implemented engaging and effective custom solutions for over a dozen rare or ultra-rare diseases: Atypical hemolytic uremic syndrome (aHUS) Cryopyrin-associated periodic syndromes (CAPS) Dupuytrens contracture Idiopathic thrombocytopenia purpura (ITP) Multiple myeloma (MM) Paroxysmal nocturnal hemoglobinuria (PNH) Philadelphia chromosomepositive chronic myelogenous leukemia (Ph+ CML) Renal cell carcinoma (RCC) Shiga toxigenic Escherichia coli infection-hemolytic uremic syndrome (STEC-HUS) Short bowel syndrome (SBS) Subependymal giant cell astrocytoma (SEGA) Systemic juvenile idiopathic arthritis (SJIA) Systemic lupus erythematosus (SLE)

Connect With Us Today.


We provide impactful and inventive training solutions for sales representatives and other industry professionals tasked with the important job of informing clinicians on desperately needed therapies for patients with rare and ultra-rare diseases. Please call Roz Blumenthal, PhD, at 248.246.5398 to learn more.

You might also like